Characterization of kappa1-opioid receptor binding in human insular cortex

Sari Izenwasser, Julie K. Staley, Stephanie Cohn, Deborah C. Mash

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Mesolimbic dopaminergic neurotransmission is modulated by dynorphin peptides binding to κ-opioid receptors. The interaction between dynorphin and dopamine systems makes the κ-opioid receptor a potential drug discovery target for the development of therapeutic agents for schizophrenia and drug abuse. This study reports the specificity and parameters of [3H]U69593 binding in the insular cortex, a representative corticolimbic area of the human brain. The results demonstrate that the radioligand [3H]U69593 labels a single population of receptors in human insular cortex with an affinity in the low nanomolar range. The pharmacological profile for inhibition of [3H]U69593 binding was determined in this brain region using drugs known to bind to μ, κ and δ opioid receptors. The results show that κ-opioid selective agonists and antagonists inhibit binding of this ligand in human brain with comparable affinities and rank order as previously described for rat and guinea pig brain and the cloned κ1-opioid receptor subtype.

Original languageEnglish (US)
Pages (from-to)857-862
Number of pages6
JournalLife Sciences
Issue number9
StatePublished - Jul 23 1999

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Characterization of kappa<sub>1</sub>-opioid receptor binding in human insular cortex'. Together they form a unique fingerprint.

Cite this